Reconstituted peptide: Keep refrigerated at 28C
A dihydropyridine calcium channel blocker, nilvadipine has demonstrated promise in the treatment of hypertension and has been studied for possible advantages in AD
Biophysical characterization of bacterial GGTs has been done to understand the molecular basis of enzyme stability
Oral semaglutide (the Wegovy pill) Novo Nordisk launched an oral form of semaglutide for weight loss in the US in January 2026
It likely sequesters key binding partners such as ATF4 and C/EBP, preventing them from activating the CHAC1 gene ( CHAC1 promoter, allows for precise control of cell fate under prolonged ER stress ( The conservation of this regulatory axis is highlighted in other models
In a phase 2 clinical trial for obesity, 26 weeks of efinopegdutide (doses 5 to 10mg) resulted in up to 11.8% WL in people with obesity (without diabetes) compared to 7.5% WL with liraglutide 3 mg and 1.8% WL with placebo [77, 78]